05 — Sector

Healthcare & Life Sciences

Health is the government’s largest spending area, and privatisation, new capacity and pharmaceutical localization are opening space for private operators, suppliers and partners.

Key figures

Government spending on health and social development in the first half of 2026, the largest sector
SAR 170.6bn1
Targeted rise in the private sector’s share of health spending by 2030
25% → 35%2
PPP contracts targeted by 2030 across 18 sectors, including health
220+3
  1. Ministry of Finance, via Argaam, July 2026
  2. US International Trade Administration, May 2026
  3. National Center for Privatization, January 2026

What is driving demand

  • Privatisation of hospitals and primary care through health clusters
  • PPP projects under the National Privatization Strategy
  • Localization of priority medicines and medical devices
  • The National Biotechnology Strategy and clinical research

Who buys

  • NUPCO, the PIF-owned company that centrally procures medicines, medical supplies and devices for public healthcare
  • Health Holding Company and the regional health clusters
  • Private hospital groups and distributors

Typical entry route

Medical device and pharmaceutical companies usually appoint a local authorised representative or distributor to handle registration and distribution, then consider local manufacturing to benefit from localization preferences.

How we help

  1. 01

    Market assessment

    Demand by product and channel, from NUPCO tenders to private hospital groups, before you commit a registration budget.

  2. 02

    Distributor search

    Distributors and authorised representatives screened for SFDA licences, storage, tender record and service capability.

  3. 03

    Licensing route

    The registration path and a realistic timeline for your products, and who must hold which licence.

Request a sector briefing

Watch for

  • SFDA registration: allow three to six months for a standard medical-device file, and longer for medicines
  • Several healthcare services still require a Saudi partner
  • Price pressure from centralised procurement through NUPCO

FAQ

Common questions

Can a foreign company own a healthcare provider in Saudi Arabia?

Some healthcare services still require a Saudi partner. Rules differ by activity, so we check the current position before you commit to a structure.

How do medical devices reach the market?

Devices are classified A to D by risk. Most need a Medical Device Marketing Authorisation from the Saudi Food and Drug Authority, filed through a licensed local authorised representative if you have no Saudi entity; allow three to six months for a standard file. Medicines follow a separate, usually longer drug-registration route.

Who buys for public hospitals?

Mostly NUPCO, the national unified procurement company owned by the Public Investment Fund, which tenders medicines, supplies and devices centrally for public healthcare. Supplier registration and tender tracking with NUPCO run alongside SFDA registration.

Where is the privatisation opportunity?

In PPPs and in the transfer of hospitals and primary-care centres to private operators, as the private share of health spending rises toward 35% by 2030.

Sources for this page: Ministry of Finance (July 2026); US International Trade Administration (May 2026); National Center for Privatization (January 2026); Saudi Food and Drug Authority, medical device requirements; Public Investment Fund, NUPCO.

Have an opportunity in mind, or looking for one?

Tell us your sector and ambition. Within one business day we will reply with an honest first view of where the opportunity is and, if it fits, a scope for an Opportunity Scan.

Discuss an opportunity